Genesis Clinical Laboratory is categorized under Testing Laboratories in Berwyn, IL and active since 2005.
Genesis Clinical Laboratory was established in 2005, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Testing Laboratories business, which does work in the B2B market, and is classified as a Testing Laboratories, under code number 541380 by the NAICS.
If you are seeking more information, feel free to contact Kim Merick at the company’s single location by writing to 3231 Euclid Avenue # 3, Berwyn, Illinois IL 60402 or by phoning (708) 484-3280. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Genesis Clinical Laboratory |
| Contact Person: | Kim Merick |
| Address: | 3231 Euclid Avenue # 3, Berwyn, Illinois 60402 |
| Phone Number: | (708) 484-3280 |
| Website Address: | genesislab.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2005 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Testing Laboratories |
| SIC Code: | 8734 |
| NAICS Code: | 541380 |
| Share This Business: |
Genesis Clinical Laboratory was started in 2005 to provide professional Testing Laboratories under the SIC code 8734 and NAICS code 541380. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Kim Merick for inquiries that concern Genesis Clinical Laboratory by calling the company number (708) 484-3280, as your correspondence is most welcome. Additionally, the physical location of the single location of Genesis Clinical Laboratory can be found at the coordinates 41.832909,-87.791361 as well as the street address 3231 Euclid Avenue # 3 in Berwyn, Illinois 60402.
For its online presence, you may visit Genesis Clinical Laboratory’s website at genesislab.com and engage with its social media outlets through on Twitter and on Facebook.